Susquehanna Fundamental Investments, LLC Mesoblast LTD Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.48 - $3.48 $7,286 - $52,829
-15,181 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$3.58 - $4.98 $7,876 - $10,956
-2,200 Reduced 12.66%
15,181 $64,000
Q4 2021

Feb 14, 2022
SELL
$4.17 - $7.09 $27,351 - $46,503
-6,559 Reduced 27.4%
17,381 $83,000
Q3 2021

Nov 15, 2021
SELL
$5.87 - $7.85 $15,849 - $21,195
-2,700 Reduced 10.14%
23,940 $144,000
Q2 2021

Aug 11, 2021
BUY
$6.69 - $9.0 $178,221 - $239,760
26,640 New
26,640 $199,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $3.04B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email